1 | free | 11,689 |
2 | peroxyl | 30 |
3 | semiquinone | 16 |
4 | peroxy | 14 |
5 | 17-oh | 10 |
6 | free-survival | 8 |
7 | carbon-centered | 7 |
8 | nitroxyl | 7 |
9 | thiyl | 7 |
10 | 2-diphenyl-1-picrylhydrazyl | 6 |
11 | dpph-free | 6 |
12 | antibody-bound | 5 |
13 | phenoxyl | 5 |
14 | uncleaved | 5 |
15 | 3'-hydroxy | 4 |
16 | lipid-bound | 4 |
17 | mid-region | 4 |
18 | subluteal-phase | 4 |
19 | un-ionized | 4 |
20 | 0.5-µg | 3 |
21 | 07/118 | 3 |
22 | ethynil | 3 |
23 | log10-transformed | 3 |
24 | peroxyacetyl | 3 |
25 | treatment.• | 3 |
26 | 17-hydroxy | 2 |
27 | 17oh | 2 |
28 | 4'-trimethoxy | 2 |
29 | 50μg/day | 2 |
30 | 6-c-hexosyl-8-c-pentosyl | 2 |
31 | 6-c-pentosyl-8-c-hexosyl | 2 |
32 | amminium | 2 |
33 | azomethines | 2 |
34 | co-processing | 2 |
35 | deltaai | 2 |
36 | hydroperoxyl | 2 |
37 | long‑term | 2 |
38 | non-exchangeable | 2 |
39 | pyroglutamylated | 2 |
40 | weight/total | 2 |
41 | ≥10-letter | 2 |
42 | -12.4° | 1 |
43 | -36.2° | 1 |
44 | -8.0° | 1 |
45 | 1,25d₃-marrs-mediated | 1 |
46 | 1,600mg/d | 1 |
47 | 1.5+ | 1 |
48 | 17-α-oh | 1 |
49 | 2-diphenyl-picrylhydrazyl | 1 |
50 | 3'-dimethoxy | 1 |
51 | 3-methylgluraryl | 1 |
52 | 4'-dimethoxy | 1 |
53 | =ctc | 1 |
54 | accupoints | 1 |
55 | alkylation-initiated | 1 |
56 | amino-polysaccharide | 1 |
57 | anti-free | 1 |
58 | anyt | 1 |
59 | azetidin-based | 1 |
60 | calculated-bioavailable | 1 |
61 | cdk9/cyclin | 1 |
62 | chitosan/konjac | 1 |
63 | colostrum-derived | 1 |
64 | cristaline | 1 |
65 | c₃h₅· | 1 |
66 | decarboxymethyl | 1 |
67 | dentis | 1 |
68 | dihydoxylupeol | 1 |
69 | erenna | 1 |
70 | forficula | 1 |
71 | four.results | 1 |
72 | free-oxygen | 1 |
73 | frequency-the | 1 |
74 | frequency/28 | 1 |
75 | from- | 1 |
76 | gabaa/dopamine | 1 |
77 | gestonolone | 1 |
78 | ginsenosid | 1 |
79 | glucose-1-dehydrogenase | 1 |
80 | glycerol/fat | 1 |
81 | h2o2-related | 1 |
82 | high.for | 1 |
83 | homo7-lumo | 1 |
84 | hydroperoxyalkyl | 1 |
85 | hydroxy-β | 1 |
86 | ibb | 1 |
87 | incluing | 1 |
88 | incontinence-the | 1 |
89 | ketoxy | 1 |
90 | kstand | 1 |
91 | molecule-sized | 1 |
92 | n'-diarylverdazyl | 1 |
93 | n-c12 | 1 |
94 | n-nonacosanyl | 1 |
95 | nci.ctc | 1 |
96 | new/enlarged | 1 |
97 | new/newly-enlarging | 1 |
98 | ngcgm3 | 1 |
99 | non-shbg-bound | 1 |
100 | non-size-based | 1 |
101 | ofvhd | 1 |
102 | oxynitroxide | 1 |
103 | panzón | 1 |
104 | reduction-intraprostatic | 1 |
105 | resin-reliner | 1 |
106 | retinyol | 1 |
107 | rhamnosyl-di-hexosyl | 1 |
108 | score/total | 1 |
109 | self-designated | 1 |
110 | stress/free | 1 |
111 | tensiophone | 1 |
112 | time=2 | 1 |
113 | trauma.the | 1 |
114 | trl-retinyl | 1 |
115 | ubisemiquinone | 1 |
116 | vaccinee-derived | 1 |
117 | α-1,2-linked | 1 |
118 | α-propyloxy | 1 |
119 | δ0.35 | 1 |
120 | δ0.55 | 1 |
121 | ∆t50rising | 1 |
1 | -12.4° | 1 |
2 | -36.2° | 1 |
3 | -8.0° | 1 |
4 | 0.5-µg | 3 |
5 | 07/118 | 3 |
6 | 1,25d₃-marrs-mediated | 1 |
7 | 1,600mg/d | 1 |
8 | 1.5+ | 1 |
9 | 17-hydroxy | 2 |
10 | 17-oh | 10 |
11 | 17-α-oh | 1 |
12 | 17oh | 2 |
13 | 2-diphenyl-1-picrylhydrazyl | 6 |
14 | 2-diphenyl-picrylhydrazyl | 1 |
15 | 3'-dimethoxy | 1 |
16 | 3'-hydroxy | 4 |
17 | 3-methylgluraryl | 1 |
18 | 4'-dimethoxy | 1 |
19 | 4'-trimethoxy | 2 |
20 | 50μg/day | 2 |
21 | 6-c-hexosyl-8-c-pentosyl | 2 |
22 | 6-c-pentosyl-8-c-hexosyl | 2 |
23 | =ctc | 1 |
24 | accupoints | 1 |
25 | alkylation-initiated | 1 |
26 | amino-polysaccharide | 1 |
27 | amminium | 2 |
28 | anti-free | 1 |
29 | antibody-bound | 5 |
30 | anyt | 1 |
31 | azetidin-based | 1 |
32 | azomethines | 2 |
33 | calculated-bioavailable | 1 |
34 | carbon-centered | 7 |
35 | cdk9/cyclin | 1 |
36 | chitosan/konjac | 1 |
37 | co-processing | 2 |
38 | colostrum-derived | 1 |
39 | cristaline | 1 |
40 | c₃h₅· | 1 |
41 | decarboxymethyl | 1 |
42 | deltaai | 2 |
43 | dentis | 1 |
44 | dihydoxylupeol | 1 |
45 | dpph-free | 6 |
46 | erenna | 1 |
47 | ethynil | 3 |
48 | forficula | 1 |
49 | four.results | 1 |
50 | free | 11,689 |
51 | free-oxygen | 1 |
52 | free-survival | 8 |
53 | frequency-the | 1 |
54 | frequency/28 | 1 |
55 | from- | 1 |
56 | gabaa/dopamine | 1 |
57 | gestonolone | 1 |
58 | ginsenosid | 1 |
59 | glucose-1-dehydrogenase | 1 |
60 | glycerol/fat | 1 |
61 | h2o2-related | 1 |
62 | high.for | 1 |
63 | homo7-lumo | 1 |
64 | hydroperoxyalkyl | 1 |
65 | hydroperoxyl | 2 |
66 | hydroxy-β | 1 |
67 | ibb | 1 |
68 | incluing | 1 |
69 | incontinence-the | 1 |
70 | ketoxy | 1 |
71 | kstand | 1 |
72 | lipid-bound | 4 |
73 | log10-transformed | 3 |
74 | long‑term | 2 |
75 | mid-region | 4 |
76 | molecule-sized | 1 |
77 | n'-diarylverdazyl | 1 |
78 | n-c12 | 1 |
79 | n-nonacosanyl | 1 |
80 | nci.ctc | 1 |
81 | new/enlarged | 1 |
82 | new/newly-enlarging | 1 |
83 | ngcgm3 | 1 |
84 | nitroxyl | 7 |
85 | non-exchangeable | 2 |
86 | non-shbg-bound | 1 |
87 | non-size-based | 1 |
88 | ofvhd | 1 |
89 | oxynitroxide | 1 |
90 | panzón | 1 |
91 | peroxy | 14 |
92 | peroxyacetyl | 3 |
93 | peroxyl | 30 |
94 | phenoxyl | 5 |
95 | pyroglutamylated | 2 |
96 | reduction-intraprostatic | 1 |
97 | resin-reliner | 1 |
98 | retinyol | 1 |
99 | rhamnosyl-di-hexosyl | 1 |
100 | score/total | 1 |
101 | self-designated | 1 |
102 | semiquinone | 16 |
103 | stress/free | 1 |
104 | subluteal-phase | 4 |
105 | tensiophone | 1 |
106 | thiyl | 7 |
107 | time=2 | 1 |
108 | trauma.the | 1 |
109 | treatment.• | 3 |
110 | trl-retinyl | 1 |
111 | ubisemiquinone | 1 |
112 | un-ionized | 4 |
113 | uncleaved | 5 |
114 | vaccinee-derived | 1 |
115 | weight/total | 2 |
116 | α-1,2-linked | 1 |
117 | α-propyloxy | 1 |
118 | δ0.35 | 1 |
119 | δ0.55 | 1 |
120 | ∆t50rising | 1 |
121 | ≥10-letter | 2 |
1 | 1.5+ | 1 |
2 | from- | 1 |
3 | n-c12 | 1 |
4 | time=2 | 1 |
5 | ngcgm3 | 1 |
6 | δ0.35 | 1 |
7 | δ0.55 | 1 |
8 | 07/118 | 3 |
9 | frequency/28 | 1 |
10 | forficula | 1 |
11 | erenna | 1 |
12 | ibb | 1 |
13 | chitosan/konjac | 1 |
14 | reduction-intraprostatic | 1 |
15 | nci.ctc | 1 |
16 | =ctc | 1 |
17 | 1,600mg/d | 1 |
18 | new/enlarged | 1 |
19 | α-1,2-linked | 1 |
20 | log10-transformed | 3 |
21 | carbon-centered | 7 |
22 | non-size-based | 1 |
23 | azetidin-based | 1 |
24 | 1,25d₃-marrs-mediated | 1 |
25 | alkylation-initiated | 1 |
26 | h2o2-related | 1 |
27 | pyroglutamylated | 2 |
28 | self-designated | 1 |
29 | uncleaved | 5 |
30 | vaccinee-derived | 1 |
31 | colostrum-derived | 1 |
32 | un-ionized | 4 |
33 | molecule-sized | 1 |
34 | ofvhd | 1 |
35 | ginsenosid | 1 |
36 | kstand | 1 |
37 | lipid-bound | 4 |
38 | non-shbg-bound | 1 |
39 | antibody-bound | 5 |
40 | amino-polysaccharide | 1 |
41 | oxynitroxide | 1 |
42 | free | 11,689 |
43 | dpph-free | 6 |
44 | anti-free | 1 |
45 | stress/free | 1 |
46 | incontinence-the | 1 |
47 | frequency-the | 1 |
48 | trauma.the | 1 |
49 | non-exchangeable | 2 |
50 | calculated-bioavailable | 1 |
51 | cristaline | 1 |
52 | gabaa/dopamine | 1 |
53 | tensiophone | 1 |
54 | gestonolone | 1 |
55 | semiquinone | 16 |
56 | ubisemiquinone | 1 |
57 | subluteal-phase | 4 |
58 | glucose-1-dehydrogenase | 1 |
59 | new/newly-enlarging | 1 |
60 | ∆t50rising | 1 |
61 | co-processing | 2 |
62 | incluing | 1 |
63 | 0.5-µg | 3 |
64 | 17-oh | 10 |
65 | 17-α-oh | 1 |
66 | 17oh | 2 |
67 | deltaai | 2 |
68 | score/total | 1 |
69 | weight/total | 2 |
70 | free-survival | 8 |
71 | ethynil | 3 |
72 | dihydoxylupeol | 1 |
73 | retinyol | 1 |
74 | decarboxymethyl | 1 |
75 | thiyl | 7 |
76 | hydroperoxyalkyl | 1 |
77 | n-nonacosanyl | 1 |
78 | trl-retinyl | 1 |
79 | 3-methylgluraryl | 1 |
80 | 6-c-hexosyl-8-c-pentosyl | 2 |
81 | 6-c-pentosyl-8-c-hexosyl | 2 |
82 | rhamnosyl-di-hexosyl | 1 |
83 | peroxyacetyl | 3 |
84 | phenoxyl | 5 |
85 | peroxyl | 30 |
86 | hydroperoxyl | 2 |
87 | nitroxyl | 7 |
88 | n'-diarylverdazyl | 1 |
89 | 2-diphenyl-1-picrylhydrazyl | 6 |
90 | 2-diphenyl-picrylhydrazyl | 1 |
91 | long‑term | 2 |
92 | amminium | 2 |
93 | free-oxygen | 1 |
94 | cdk9/cyclin | 1 |
95 | mid-region | 4 |
96 | panzón | 1 |
97 | homo7-lumo | 1 |
98 | resin-reliner | 1 |
99 | ≥10-letter | 2 |
100 | high.for | 1 |
101 | azomethines | 2 |
102 | dentis | 1 |
103 | four.results | 1 |
104 | accupoints | 1 |
105 | glycerol/fat | 1 |
106 | anyt | 1 |
107 | 50μg/day | 2 |
108 | 3'-dimethoxy | 1 |
109 | 4'-dimethoxy | 1 |
110 | 4'-trimethoxy | 2 |
111 | α-propyloxy | 1 |
112 | 3'-hydroxy | 4 |
113 | 17-hydroxy | 2 |
114 | peroxy | 14 |
115 | ketoxy | 1 |
116 | treatment.• | 3 |
117 | -8.0° | 1 |
118 | -36.2° | 1 |
119 | -12.4° | 1 |
120 | hydroxy-β | 1 |
121 | c₃h₅· | 1 |